Studie | Rekrutierungszeitraum | Studienpatienten |
---|---|---|
CLL1 | 09/1997 - 12/2004 | 877 |
CLL2 | 1997 - 1998 | 78 |
CLL2-BAAG | 01/2019 - 06/2020 | 46 |
CLL2-BAG | 05/2015 - 01/2016 | 66 |
CLL2-BCG | 05/2015 - 06/2019 | 48 |
CLL2-BIG | 01/2015 - 08/2015 | 66 |
CLL2-BIO | 02/2016 - 10/2016 | 66 |
CLL2-BZAG | 11/2020 - Q4/2022 | 42 |
CLL2-GIVe | 09/2016 - 10/2018 | 41 |
CLL2B | 1998 - 1999 | 30 |
CLL2C | 08/1999 - 02/2001 | 34 |
CLL2E | 2000 - 2001 | 16 |
CLL2G | 06/2003 - 07/2008 | 60 |
CLL2H | 09/2002 - 02/2006 | 109 |
CLL2i | 11/2003 - 11/2007 | 13 |
CLL2K | 07/2004 - 11/2007 | 59 |
CLL2L | 03/2005 - 11/2008 | 61 |
CLL2M | 03/2006 - 09/2008 | 195 |
CLL2o | 01/2008 - 12/2011 | 131 |
CLL2P | 04/2011 - 06/2013 | 22 |
CLL2s | 05/2012 - 01/2013 | 3 |
CLL3 | 01/1997 - 09/2002 | 216 |
CLL3C | 08/2001 - 09/2004 | 53 |
CLL3R (D) | 07/2002 - 07/2007 | 36 |
CLL3X | 06/2001 - 03/2007 | 100 |
CLL4 | 06/1999 - 07/2003 | 375 |
CLL4B | 06/2001 - 07/2002 | 23 |
CLL5 | 08/1999 - 09/2004 | 206 |
CLL6 | 09/1999 - 09/2003 | 83 |
CLL7 (D, A, CH) | 10/2005 - 01/2010 | 423 |
CLL8 | 07/2003 - 04/2006 | 817 |
CLL9 | 12/2004 - 04/2008 | 97 |
CLL10 | 10/2008 - 07/2011 | 564 |
CLL11 | 04/2010 - 07/2012 | 781 |
CLL12 | 04/2014 - 02/2019 | 515 |
CLL13 | 12/2016 - 10/2019 | 926 |
CLL14 | 08/2015 - 08/2016 | 432 |
CLL16 | Q2/2022 - offen | 20 |
CLL17 | 03/2021 - 11/2022 | 909 |
CLL-Frail | 05/2021 - offen | 48 |
CLLM1 | 07/2012 - 01/2016 | 89 |
CLLR3 | 11/2014 - 12/2017 | 27 |
CLL-RT1 | 02/2020 - Q4/2022 | 59 |
CLLRUmbrella1 | 12/2016 - 01/2019 | 35 |
CLLRUmbrella2 | 04/2017 - 09/2018 | 36 |
CLLTX1 | 11/2017 - 04/2018 | 3 |
LGL1 | 08/2005 - 05/2010 | 13 |
PLL1 | 09/1999 - 11/2003 | 21 |
T-PLL1 | 11/2001 - 02/2007 | 26 |
T-PLL2 | 06/2010 - 09/2013 | 18 |
Stand 22.02.2022 | 8931 |
Patientenstand am 14.03.2023: 7154 Patienten.